Author

Wynona A. Coles

Observed names: Coles, Wynona, W Coles, Wynona Coles

Institutions: National Institutes of Health, National Heart, Lung, and Blood Institute

Observed institutions: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institutes of Health Clinical Center, National Heart, Lung, and Blood Institute Division of Intramural Research

OpenAlex ID: A5004126729

Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease

2004 · Mark T. Gladwin, Vandana Sachdev, et al. · New England Journal of Medicine · 1,331

Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype

2014 · Matthew M. Hsieh, Courtney D. Fitzhugh, et al. · JAMA · 354

Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell Disease

2007 · Vandana Sachdev, Roberto F. Machado, et al. · Journal of the American College of Cardiology · 325

PDF

Divergent Nitric Oxide Bioavailability in Men and Women With Sickle Cell Disease

2003 · Mark T. Gladwin, Alan N. Schechter, et al. · Circulation · 273

PDF

Hemodynamic and Functional Assessment of Patients with Sickle Cell Disease and Pulmonary Hypertension

2007 · Anastasia Anthi, Roberto F. Machado, et al. · American Journal of Respiratory and Critical Care Medicine · 270

Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension

2005 · Roberto F. Machado, Sabrina Martyr, et al. · British Journal of Haematology · 212

Levels of soluble endothelium‐derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality

2005 · Gregory J. Kato, Sabrina Martyr, et al. · British Journal of Haematology · 207

At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT

2017 · Courtney D. Fitzhugh, Stefan Cordes, et al. · Blood · 171

Severity of pulmonary hypertension during vaso‐occlusive pain crisis and exercise in patients with sickle cell disease

2006 · Roberto F. Machado, A. Kyle Mack, et al. · British Journal of Haematology · 122

PDF

Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT

2017 · Courtney D. Fitzhugh, Matthew M. Hsieh, et al. · Blood Advances · 105

Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease

2009 · Caterina P. Minniti, Roberto F. Machado, et al. · British Journal of Haematology · 82

Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia

2015 · Courtney D. Fitzhugh, Matthew M. Hsieh, et al. · PLoS ONE · 64

PDF

Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerism

2022 · Rialnat A. Lawal, Devdeep Mukherjee, et al. · Blood · 44

Reversal of pre-capillary pulmonary hypertension in a patient with sickle cell anemia who underwent haploidentical peripheral blood stem cell transplantation

2017 · C Pittman, M M Hsieh, et al. · Bone Marrow Transplantation · 23

Pulmonary Hypertension in Sickle Cell Disease: Cardiopulmonary Evaluation and Response to Chronic Phosphodiesterase 5 Inhibitor Therapy.

2004 · Roberto F. Machado, Sabrina E. Martyr, et al. · Blood · 16

Two Nonmyeloablative HLA-Matched Related Donor Allogeneic Hematopoietic Cell Transplantation Regimens in Patients with Severe Sickle Cell Disease

2025 · Zaina Inam, Neal Jeffries, et al. · Transplantation and Cellular Therapy · 10

Acute on Chronic Pulmonary Hypertension in Patients with Sickle Cell Disease.

2004 · Gregory J. Kato, Sabrina Martyr, et al. · Blood · 10

Atorvastatin Therapy Restores Nitric Oxide-Dependent Vascular Responsiveness in Patients with Sickle Cell Disease.

2004 · Gregory J. Kato, Christian Hunter, et al. · Blood · 8

The Sickle Cell-Pulmonary Hypertension Screening Study: ECHO Findings at Two-Years of Follow Up.

2005 · Oswaldo Castro, Gregory Kato, et al. · Blood · 7

Bone Marrow Characterization in Sickle Cell Disease: Inflammation and Stress Erythropoiesis Lead to Suboptimal CD34 Recovery Compared to Normal Volunteer Bone Marrow

2017 · Alexis Leonard, Aylin Bonifacino, et al. · Blood · 6

At Least 20% Donor Myeloid Chimerism Is Necessary to Reverse the Sickle Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation

2016 · Courtney D. Fitzhugh, Matthew M. Hsieh, et al. · Blood · 4

Infusion of hemolyzed red blood cells within peripheral blood stem cell grafts in patients with and without sickle cell disease

2012 · Courtney D. Fitzhugh, Hayato Unno, et al. · Blood · 4

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Patients with Severe Sickle Cell Disease (SCD)

2011 · Matthew M Hsieh, Courtney D Fitzhugh, et al. · Blood · 3

Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients with Sickle Cell Disease.

2005 · Vandana Sachdev, Roberto F. Machado, et al. · Blood · 3

A machine learning‐based workflow for predicting transplant outcomes in patients with sickle cell disease

2024 · Haiou Li, Vandana Sachdev, et al. · British Journal of Haematology · 2

PDF

Works count: 38

Citation count: 3,658

H-index: 15

I10-index: 17